Clinical Trials Directory

Trials / Completed

CompletedNCT03464344

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

COrtical Superficial Siderosis and REcurrent Lobar Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
170 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in the elderly with high risk of recurrence. The investigators aim to determine the relationship between cortical superficial siderosis (cSS), a MRI hemorrhagic marker of CAA and the risk of symptomatic ICH recurrence in a multicentric prospective cohort of patients with acute lobar ICH related to CAA. The investigators hypothesize that patients with cSS have an increased risk of recurrent symptomatic ICH relative to those without cSS.

Detailed description

Patients with acute lobar ICH fulfilling the Boston criteria for probable or possible CAA will be enrolled within 30 days after ICH onset. Brain MRI performed at baseline will be analyzed blinded to clinical data. Patients with presence of cSS will be compared with those without cSS. During a systematic follow-up of 24 months, patients will undergo neurological, neuropsychological and MRI evaluation. The investigators will compare the rate of recurrent symptomatic ICH at 24 months in patients with vs. without cSS.

Conditions

Interventions

TypeNameDescription
OTHERneurological, neuropsychological and MRI evaluationneurological, neuropsychological and MRI evaluation

Timeline

Start date
2018-10-12
Primary completion
2025-02-11
Completion
2025-02-11
First posted
2018-03-14
Last updated
2025-12-31

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03464344. Inclusion in this directory is not an endorsement.